Spandidos Publications invites you to Athens for the 22nd World Congress on Advances in Oncology and the 20th International Symposium on Molecular Medicine. This conference brings together experts in oncology and molecular medicine from around the world to share the latest advances in these fields.
We are proud to report that the past year was a successful one for Spandidos Publications as we continue to grow, with record numbers of papers published in our eight journals. In addition, the newly released Impact Factors (2016 Journal Citation Reports® Edition) have increased for our journals, indicating that the papers we publish continue to receive greater dissemination and are being cited more frequently compared with previous years. In addition, we are excited to announce that the London offices recently moved to brand new and larger, purpose-built premises in Hammersmith.
The scientific program for 2017 includes lectures, short oral presentations and poster presentations that include the latest discoveries and state of the art methodologies in the fields of molecular oncology and molecular medicine. The best presentations will be recognized with Certificates of Achievement at our traditional, end of Congress Award Dinner. Selected workshops, specifically the PRE-CONGRESS WORKSHOP: Next-Generation Sequencing – Library construction and quality control (theoritical), are organized annually and are based on the development and scientific trends of novel fields in medicine and oncology. In addition, the participation of several scientific members, primarily occupied in multinational industrial companies, presents a novel aspect of our conference that facilitates the presentation of the latest technologies and services in clinical diagnostics and therapy.
While in Athens, we hope you will have time to explore some of the cultural and historic landmarks of Greece. Our Congress tours include excursions to Mycenae, Nauplio, Epidaurus, The story of the “Marathon Race”, Sparta and Mistras, an Athens city tour, and a cruise to the beautiful Saronic Gulf islands of Hydra, Poros and Aegina. The excursions offer an excellent opportunity to meet old friends and make new contacts while exploring the magnificent attractions.
If you would like to participate in our conference please visit our website www.spandidos-publications.com and register online.
We thank you for your participation in our Congress and hope that you enjoy your visit to our conference and Greece.
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Adult and Pediatric Patients with Classical Hodgkin Lymphoma (cHL) Refractory to Treatment, or Who Have Relapsed After Three or More Prior Lines of Therapy
20th March, 2017